Gimmune GmbH was established in 2008. We developed and patented novel anti-cancer/viral compounds, anti-glycan antibodies, and nano-devices
Gimmune GmbH was established in 2008. We developed and patented novel anti-cancer/viral compounds, anti-glycan antibodies, and nano-devices
Products
Nano-electrophoresis and nano in micro arrays for single-cell analysis
Novel anti-cancer and anti-viral compounds
Anti-glyconectin monoclonal antibodies
R&D Activities
Monoclonal antibodies against carcino-embryonal markers
NK cell proliferation
Glycocalyx and Glyconectin structure and function
Collaborations
9 Universities
1 biomed company
We have exclusive rights to produce, sell and distribute above mentioned three classes of custom tailored products
Gimmune GmbH, Baarerstrasse 12, 6300 Zug, Switzerland